{"title": "Carlos A. Guzm\u00e1n", "author": "Carlos A Guzm\u00e1n", "url": "https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/carlos-a-guzman/", "hostname": "helmholtz-hzi.de", "description": "Head Carlos Guzm\u00e1n of the \"Vaccinology and Applied Microbiology\" Department.", "sitename": "Helmholtz Centre for Infection Research", "date": "2023-07-06", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Vaccinology and applied Microbiology\nVaccination is the most efficient strategy to prevent infectious diseases. The art of the\n[vaccine](/en/info-centre/glossary/entry/vaccine/) researcher lies in finding substances that prevent us from falling ill with diseases such as [influenza](/en/info-centre/glossary/entry/influenza/) or viral [hepatitis](/en/info-centre/glossary/entry/hepatitis/). But what makes a [vaccine](/en/info-centre/glossary/entry/vaccine/) successful and ensures effective protection? Our scientists study the reaction of the [immune system](/en/info-centre/glossary/entry/immune-system/) to answer that question \u2013 and to develop better [vaccination](/en/info-centre/glossary/entry/vaccination/) strategies.\nLeader\nProf Dr Carlos A. Guzm\u00e1n\nWhat do we need to promote protection \u2013 what type of immune response is required for a\n[vaccination]to give us robust, predictable and long-term protection against a specific pathogen?\nProf. Carlos A. Guzm\u00e1n (MD, PhD) is head of the department Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection Research and also APL professor at the Hannover Medical School.\nHe studied Medicine at the National University of Rosario and received his specialization in Medical Bacteriology in Argentina. With a scholarship from the Italian Foreign Ministry, he then conducted research at the Institute of Microbiology at the University of Genoa, Italy. He acquired his doctorate in Medicine and Surgery, becoming also a doctor in Microbiological Sciences.\nIn 1994, he moved to Germany and became head of the Vaccine Research group at the HZI, formerly\n[GBF](/en/info-centre/glossary/entry/gbf/). He has been active in the field of Vaccinology since 1989. His work led to the discovery of new adjuvants, the establishment of [Salmonella](/en/info-centre/glossary/entry/salmonella/) spp. as a delivery system for [DNA](/en/info-centre/glossary/entry/dna/) vaccines and therapeutic molecules, and the development of [vaccine](/en/info-centre/glossary/entry/vaccine/) candidates against different infectious diseases. He has published over 260 papers in international journals and is co-inventor of numerous international patents.\nProf. Guzm\u00e1n is member of the editorial boards of Bioengineered, Frontiers Microbial Immunology, Frontiers in Mucosal Immunology, Frontiers in Vaccines and Molecular Therapeutics, Vaccine, and Vaccines.\nNews\nBachelor & Master\nAre you interested in a bachelor or master thesis? We are looking forward to your request!\nVideo\nAudio Podcast\n- Ein neuer Impfstoff gegen Tuberkulose \u2013 die Infektion Nr. 1 in der WeltAlle 15 Sekunden stirbt ein Mensch an Tuberkulose. Bislang gibt es keinen ausreichend wirksamen Impfstoff gegen das Mycobacterium tuberkulosis, lediglich einen, der S\u00e4uglinge in den ersten zwei Lebensjahren sch\u00fctzt. Jetzt kristallisiert sich in klinischen Studien ein vielversprechender neuer Impfstoff heraus, den die Vakzine Projekt Management GmbH auf ihrem Weg zur Zulassung begleitet. Bernd Eisele und Leander Grode stellen Ihnen den Impfstoff vor und berichten von ihren Hoffnungen und Erwartungen\u2026\n- Turbo f\u00fcr die Impfung \u2013 neue Hilfsstoffe erm\u00f6glichen neue Impfmethoden Sie habe einen schlechten Ruf, aber ohne sie geht nichts: Impfverst\u00e4rker. Seit es Impfungen gibt, brauchen Impfstoff die Unterst\u00fctzung kleiner Molek\u00fcle. Thomas Ebensen und Rimma Libanova haben einen vielversprechenden Impfturbo entdeckt \u2013 der ganz nebenbei die gesamte Impftechnik revolutionieren k\u00f6nnte. Kommen Sie mit...\n- Influenza zwischen Schwein und Mensch - die Experten Klaus Schughart und Carlos Guzman im Gespr\u00e4ch Die Influenzawelle rollt, aber die Informationen \u00fcber Schweinegrippe, saisonale Grippe und die verschiedenen Impfstoffe sind verwirrend - teilweise be\u00e4ngstigend. Soll ich mich impfen lassen? Sind die Impfstoffe sicher? Mein Nachbar kennt aber jemanden... Die Grippe ist doch gar nicht so schlimm... Sind Sie ebenfalls unsicher? Dann lassen Sie sich die wichtigsten Fragen von unseren Experten des Helmholtz-Zentrums f\u00fcr Infektionsforschung f\u00fcr Influenza Klaus Schughart und Carlos Guzman beantworten...\n- SchnupfimpfungImpfen ohne Spritze. Darauf warten nicht nur Spritzen-Phobiker. Nasensprays sollen in Zukunft das Impfen revolutionieren. Doch es gibt ein gro\u00dfes Problem: Der Impfstoff muss zuerst durch die wehrhafte Schleimhaut, um zu seinem Ziel zu gelangen.\n[Send per email](mailto:?subject=&body=https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/carlos-a-guzman/)Share", "language": null, "image": "https://www.helmholtz-hzi.de/fileadmin/user_upload/Forschung/Forschungsgruppen/Vakzinologie/Carlos_Guzman.jpg", "pagetype": null, "links": ["/en/", "/de/forschung/forschungsschwerpunkte/immunantwort-und-interventionen/vakzinologie-und-angewandte-mikrobiologie/carlos-a-guzman/", "/en/the-hzi/", "/en/the-hzi/about-the-hzi/facts-and-figures/", "/en/the-hzi/about-the-hzi/the-hzi/", "/en/the-hzi/about-the-hzi/facts-and-figures/", "/en/the-hzi/about-the-hzi/research-reports/", "/en/the-hzi/about-the-hzi/history-1965-2006/", "/en/the-hzi/about-the-hzi/history-since-2006/", "/en/the-hzi/management/executive-management/", "/en/the-hzi/administration-infrastructure/", "/en/the-hzi/organisation-chart/", "/en/the-hzi/sites/", "/en/the-hzi/360-tour/", "/en/the-hzi/helmholtz-association/", "http://helmholtz-hzi.bibliotheca-open.de/Welcome", "/en/the-hzi/conference-building/", "/en/the-hzi/friends-of-the-hzi/", "/en/the-hzi/mission-statement/", "/en/the-hzi/gender-equality/gender-equality/", "/en/the-hzi/conflict-resolution/", "/en/the-hzi/donation/", "/en/research/research-topics/", "/en/research/mission/", "/en/research/our-research/", "/en/research/research-topics/", "/en/research/research-topics/bacterial-and-viral-pathogens/", "/en/research/research-topics/immune-response/", "/en/research/research-topics/anti-infectives/", "/en/research/research-foci/", "/en/research/research-foci/antimicrobial-resistance-amr/", "/en/research/research-foci/microbial-communities-mico/", "/en/research/research-foci/chronic-viral-infections-cvir/", "/en/research/research-foci/individualized-immune-interventions-indi/", "/en/research/research-foci/digital-and-global-health-epi/", "/en/research/research-foci/infection-and-neurodegeneration-ineu/", "/en/research/research-foci/respiratory-viral-infections-rvir/", "/en/research/research-groups/", "/en/research/technology-platforms/", "/en/research/innovation-management/", "/en/research/cooperations/research-partners/", "/en/research/publication-database/", "/en/research/good-scientific-practice/", "/fileadmin/user_upload/Infothek/Roadmap_HZI_2025/Roadmap_engl_2016_WEB_ES.pdf", "/en/research/translational-research/", "/fileadmin/user_upload/Infothek/Ueber_das_HZI/Jahresberichte/Ergebnisberichte/WEB_HZI_RReport_2022_9MB.pdf", "/fileadmin/user_upload/Infothek/Ueber_das_HZI/Jahresberichte/Ergebnisberichte/WEB_HZI_RReport_2022_9MB.pdf", "/en/career/", "/en/career/jobs/open-positions/", "/en/career/jobs/open-positions/", "/en/career/jobs/phd-theses/", "/en/career/jobs/bachelor-and-master-thesis/", "/en/career/career-paths/", "/en/career/graduate-school/application/", "/en/career/phd-programme-epidemiology/objectives/", "/en/career/embl-hzi-fellowship/general-information/", "/en/career/hzi-mcgill-exchange-program/about-the-program/", "/en/career/do-it-phd-initiative/what-we-do/", "/en/career/hzi-alumni/aims/", "/en/career/pupils/apprenticeships/", "/en/career/career-paths/", "/en/press/", "/en/press/press-releases-news/", "/en/press/gallery-download/", "/en/press/press-kit-josef-penninger/", "/en/press/media-coverage/", "/en/service/newsletter/", "/en/press/press-contacts/", "/en/press/videos-podcasts/videos/", "/en/press/magazine-infact/recent-issue/", "/en/press/brochures/", "/en/press/visitors-service/", "/en/press/press-kit-josef-penninger/", "/en/press/press-kit-josef-penninger/", "/en/info-centre/", "/en/info-centre/topics/all-topics/", "/en/info-centre/topics/germs-and-diseases/", "/en/info-centre/topics/our-immune-system/", "/en/info-centre/topics/anti-infectives/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/", "/en/info-centre/topics/germs-and-diseases/coronaviruses/", "/en/news-events/", "/en/news-events/news/", "/en/news-events/events/", "/en/news-events/research-awards/paper-of-the-month/", "/en/news-events/projects/", "/en/news-events/projects/discourse-animals-in-research/", "/en/news-events/stories/", "/en/news-events/stories/world-day-for-laboratory-animals-and-alternative-models/", "/en/news-events/stories/world-antibiotic-awareness-week-2022/", "/en/news-events/stories/one-health-triad-of-environmental-animal-and-human-health/", "/en/news-events/interview/", "/en/news-events/interview/martin-korte-long-covid-can-become-manifest-even-after-a-mild-course-of-covid-19/", "/en/news-events/interview/peggy-riese-the-corona-vaccines-were-meant-to-protect-against-severe-disease-and-that-is-what-they-do/", "/en/news-events/portrait/", "/en/news-events/portrait/christian-sieben-a-biologist-with-nano-vision/", "/en/news-events/portrait/susanne-talay-a-little-outbreak-every-day/", "/en/news-events/portrait/antoine-emmanuel-saliba-shining-a-spotlight-on-the-cellular-mechanism/", "/en/news-events/stories/coronavirus-sars-cov-2/", "/en/news-events/stories/coronavirus-sars-cov-2/", "/en/", "/en/research/research-topics/", "/en/research/research-topics/", "/en/research/research-topics/immune-response/", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/our-research/", "/en/info-centre/glossary/entry/vaccine/", "/en/info-centre/glossary/entry/influenza/", "/en/info-centre/glossary/entry/hepatitis/", "/en/info-centre/glossary/entry/vaccine/", "/en/info-centre/glossary/entry/immune-system/", "/en/info-centre/glossary/entry/vaccination/", null, "tel:+49-531-6181-4600", "/en/nc/service/contact/person/carlos-a-guzman/", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/our-research/#anchorsection", "/en/nc/research/research-topics/immune-response/vaccinology-and-applied-microbiology/team/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/technology-offers/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/projects/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/further-groups-of-the-department/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/publications/#anchorsection", "/en/info-centre/glossary/entry/vaccination/", "/en/info-centre/glossary/entry/gbf/", "/en/info-centre/glossary/entry/salmonella/", "/en/info-centre/glossary/entry/dna/", "/en/info-centre/glossary/entry/vaccine/", "/en/news-events/news/view/article/complete/forschungskooperation-zu-neuartigen-impfstoffen-gegen-krankheitserreger-der-magen-darm-schleimhaut-g/", "/en/news-events/news/view/article/complete/infektionserreger-bietet-schutz-vor-leberkrebs/", "/en/news-events/news/view/article/complete/antiviral-und-entzuendungshemmend0/", "javascript:if(window.print)window.print()", "mailto:?subject=&body=https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/carlos-a-guzman/", "https://www.facebook.com/sharer/sharer.php?u=https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/carlos-a-guzman/%2F&src=sdkpreparse", "https://twitter.com/intent/tweet?text=Check%20this%20page%20https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/carlos-a-guzman/", "/en/press/", "https://buendnis.niedersachsen.de/startseite/", "https://www.helmholtz-klima.de/en", "https://www.charta-der-vielfalt.de/en/", "https://www.initiative-transparente-tierversuche.de/", "https://www.facebook.com/helmholtz.hzi", "https://twitter.com/Helmholtz_HZI", "https://de.linkedin.com/company/helmholtz-centre-for-infection-research", "https://www.youtube.com/channel/UC1P_GFvzrKeCgD4z4h4sKDQ", "/en/service/feeds/", "/en/service/newsletter/", "tel:+495316181-0", "/en/nc/service/contact/person/helmholtz-centre-for-infection-research-hzi/", "tel:+49531-6181-0", "/en/nc/service/contact/person/helmholtz-centre-for-infection-research-hzi/", "/en/the-hzi/sites/campus-braunschweig/", "tel:+49-531-391-55100", "/en/nc/service/contact/person/braunschweig-integrated-centre-of-systems-biology-brics/", "/en/the-hzi/sites/braunschweiger-integrated-centre-of-systems-brics/about-brics/", "tel:+49-511-220027-0", "/en/nc/service/contact/person/twincore-centre-for-experimental-and-clinical-infection-research/", "/en/the-hzi/sites/twincore-centre-for-experimental-and-clinical-infection-research/about-twincore/", "tel:+49-511-5350-8500", "/en/nc/service/contact/person/hzi-study-centre/", "/en/the-hzi/sites/study-centre-crc/", "tel:+49-511-5350-8658", "/en/nc/service/contact/person/centre-for-individualised-infection-medicine-ciim/", "/en/the-hzi/sites/centre-for-individualised-infection-medicine-ciim/", "tel:+49-40-8998-3672", "/en/nc/service/contact/person/centre-for-structural-systems-biology-cssb/", "/en/the-hzi/sites/centre-for-structural-systems-biology-cssb/", "tel:+49-681-98806-0", "/en/nc/service/contact/person/helmholtz-institute-for-pharmaceutical-research-saarland-hips/", "/en/the-hzi/sites/helmholtz-institute-for-pharmaceutical-research-saarland-hips/about-hips/", "tel:+49-931-31-89587", "mailto:info@helmholtz-hiri.de", "/en/the-hzi/sites/helmholtz-institute-for-rna-based-infection-research-hiri/", "tel:+49-3834-420-5501", "mailto:hioh-info@helmholtz-hzi.de", "/en/the-hzi/sites/helmholtz-institute-for-one-health-hioh/", "/en/the-hzi/sites/campus-braunschweig/", "/en/the-hzi/sites/braunschweiger-integrated-centre-of-systems-brics/about-brics/", "/en/the-hzi/sites/helmholtz-institute-for-pharmaceutical-research-saarland-hips/about-hips/", "/en/the-hzi/sites/twincore-centre-for-experimental-and-clinical-infection-research/about-twincore/", "/en/the-hzi/sites/study-centre-crc/", "/en/the-hzi/sites/centre-for-individualised-infection-medicine-ciim/", "/en/the-hzi/sites/centre-for-structural-systems-biology-cssb/", "/en/the-hzi/sites/helmholtz-institute-for-one-health-hioh/", "/en/the-hzi/sites/helmholtz-institute-for-rna-based-infection-research-hiri/", "/en/nc/service/contact/", "/en/service/imprint/", "/en/service/sitemap/", "/en/service/newsletter/", "/en/service/data-protection/", "https://whistlefox.heuking.de/start/hzi-gmbh/en", "https://www.helmholtz.de"]}